MicroRNA-200a suppresses metastatic potential of side population cells in human hepatocellular carcinoma by decreasing ZEB2

Oncotarget

Volumn 6, Issue 10, 2015, Pages 7918-7929

  Yang, Xisheng ^a   Wang, Jianlin ^a   Qu, Shibin ^a   Zhang, Hongtao ^a   Ruan, Bai ^a   Gao, Yuan ^a   Ma, Ben ^a   Wang, Xing ^a   Wu, Nan ^a   Li, Xiaolei ^a   Dou, Kefeng ^a   Li, Haimin ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Metastasis; MicroRNAs; Side population

Indexed keywords

MICRORNA 200A; PROTEIN ZEB2; TRANSCRIPTION FACTOR; TUMOR MARKER; UNCLASSIFIED DRUG; UVOMORULIN; HOMEODOMAIN PROTEIN; MICRORNA; MIRN200 MICRORNA, HUMAN; REPRESSOR PROTEIN; ZEB2 PROTEIN, HUMAN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PROGNOSIS; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; LUNG METASTASIS; LUNG NODULE; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; MIDDLE AGED; MOUSE; NONHUMAN; OVERALL SURVIVAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SIDE POPULATION CELL; SURVIVAL TIME; CELL PROLIFERATION; GENETICS; LIVER TUMOR; METABOLISM; METASTASIS; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR CELL LINE;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM METASTASIS; PROGNOSIS; REPRESSOR PROTEINS; SURVIVAL ANALYSIS;

EID: 84928405229     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.3486     Document Type: Article

References (35)

1. Limin Xia, Wenjie Huang, Dean Tian, Lin Zhang, Xingshun Qi, Zhangqian Chen, Xin Shang, Yongzhan Nie, Kaichun Wu. Forkhead Box Q1 Promotes Hepatocellular Carcinoma Metastasis by Transactivating ZEB2 and VersicanV1 Expression. Hepatology. 2014; 59:958-973.
2. Beachy PA, Karhadkar SS, Berman DM. Tissue repair and stem cell renewal in carcinogenesis. Nature. 2004;432:324-331.
3. Li C, Wu JJ, Hynes M, Dosch J, Sarkar B, Welling TH, Pasca di Magliano M, Simeone DM. c-Met Is a Marker of Pancreatic Cancer Stem Cells and Therapeutic Target. Gastroenterology. 2011; 141:2218-2227.
4. Wu C, Alman BA. Side population cells in human cancers. Cancer Lett. 2008;268:1-9.
5. Van den Broeck A, Vankelecom H, Van Delm W, Gremeaux L, Wouters J, Allemeersch J, Govaere O, Roskams T, Topal B. Human Pancreatic Cancer Contains a Side Population Expressing Cancer Stem Cell-Associated and Prognostic Genes. Plos One. 2013; 8 (9): e73968.
6. Wenjuan Qi, Chao Zhao, Lijun Zhao. Sorting and identification of side population cells in the human cervical cancer cell line HeLa. Cancer Cell International. 2014; 14(1).
7. Hadnagy A, Gaboury L, Beaulieu R, Balicki D. SP analysismay be used to identify cancer stem cell populations. Exp Cell Res. 2006; 312:3701-3710.
8. Tsai HC, Su HL, Huang CY, Fong YC, Hsu CJ and Tang CH. CTGF increases matrix metalloproteinases expression and subse-quently promotes tumor metastasis in human osteosarcoma through down-regulating miR-519d. Oncotarget. 2014; 5(11):3800-3812.
9. Zhou HC, Fang JH, Luo X, Zhang L, Yang J, Zhang C, Zhuang SM. Downregulation of microRNA-100 enhances the ICMT-Rac1 signaling and promotes metastasis of hepatocellular carcinoma cells. Oncotarget. 2014; 5(23):12177-88.
10. He L, Thomson JM, Hemann MT. A microRNA polycistron as a potential human oncogene. Nature. 2005; 435:828-833.
11. Senanyake U, Das S, Vesely P. Mir-192, mir-194, mir-215, mir-200c and mir-141 are downregulated and their common target acvr2b is strongly expressed in renal childhood neoplasms. Carcinogenesis. 2012; 33:1014-1021.
12. Choi PS, Zakhary L, Choi W-Y. Members of the mirna-200 family regulate olfactory neurogenesis. Neuron. 2008; 57:41-55.
13. Leskelä S, Leandro-García LJ, Mendiola M. The mir-200 family controls β-tubulin expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients. Endocr Relat Cancer. 2011; 18:85-95.
14. Korpal M, Lee ES, Hu G, Yibin Kang. The miR-200 family inhibits epithelialmesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem. 2008; 283:14910-14914.
15. Paterson EL, Kolesnikoff N, Gregory PA. The microRNA-200 family regulates epithelial to mesenchymal transition. Sci World J. 2008; 8:901-904.
16. Hu XX, Macdonald DM, Huettner PC, Feng ZH, El Naqa IM, Schwarz JK, Mutch DG, Grigsby PW, Powell SN, Wang XW. A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer. Gynecol Oncol. 2009; 114:457-464.
17. Maria Koutsaki, Demetrios A. Spandidos, Apostolos Zaravinos. Epithelial-mesenchymal transition-associated miRNAs in ovarian carcinoma, with highlight on the miR-200 family: Prognostic value and prospective role in ovarian cancer therapeutics. Cancer Letters. 2014; 351:173-181.
18. Samy Lamouille, Jian Xu, Rik Derynck. Molecular mechanisms of epithelial-mesenchymal transition. Nature. 2014; 15:178-196.
19. Gregory. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nature Cell Biol. 2008; 10:593-601.
20. Samavarchi-Tehrani. Functional genomics reveals a BMPdriven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell. 2010; 7:64-77.
21. Ren Li, Niansong Qian, Kaishan Tao, Nan You, Xinchuan Wang, Kefeng Dou. MicroRNAs involved in neoplastic transformation of liver cancer stem cells. Journal of Experimental & Clinical Cancer Research. 2010; 29:1-10.
22. Jie Liu, Bai Ruan, Nan You, Qike Huang, Weihui Liu, Zheng Dang, Weihua Xu, Ti Zhou, Ru Ji, Yang Cao, Xia Li, Desheng Wang, Kaishan Tao, et al. Downregulation of miR-200a Induces EMT Phenotypes and CSC-like Signatures through Targeting the β-catenin Pathway in Hepatic Oval Cells. Plos one. 2013; 8:e79409.
23. Hill L. ZEB/miR-200 feedback loop: at the crossroads of signal transduction in cancer. Int J Cancer. 2013; 132:745-754.
24. Li Y, Xu D, Bao C, Zhang Y, Chen D, Zhao F, Ding J, Liang L, Wang Q, Liu L, Li J, Yao M, Huang S, He X. MicroRNA-135b, a HSF1 target, promotes tumor invasion and metastasis by regulating RECK and EVI5 in hepatocellular carcinoma. Oncotarget. 2014; [Epub ahead of print].
25. Zhang X, Cheng SL, Bian K, Wang L, Zhang X, Yan B, Jia LT, Zhao J, Gammoh N, Yang AG, Zhang R. MicroRNA-26a promotes anoikis in human hepatocellular carcinoma cells by targeting alpha5 integrin. Oncotarget. 2014; [Epub ahead of print].
26. Melina-Theoni Gyparaki, Efthimia K. Basdra, Athanasios G. Papavassiliou. MicroRNAs as regulatory elements in triple negative breast cancer. Cancer Letters. 2014; 354:1-4.
27. Wenjuan Qi, Chao Zhao, Lijun Zhao, Ning Liu, Xiaoping Li, Weidong Yu, Lihui Wei. Sorting and identification of side population cells in the human cervical cancer cell line HeLa. Cancer Cell International. 2014; 14:3.
28. Liu LL, Lu SX, Li M, Li LZ, Fu J, Hu W, Yang YZ, Luo RZ, Zhang CZ, Yun JP. FoxD3-regulated microRNA-137 suppresses tumour growth and metastasis in human hepatocellular carcinoma by targeting AKT2. Oncotarget. 2014; 5(13):5113-24.
29. Xu, J., Lamouille, S. & Derynck, R. TGF-β-induced epithelial to mesenchymal transition. Cell Res. 2009; 19:156-172.
30. Sánchez-Tilló E, Lázaro A, Torrent R, Cuatrecasas M, Vaquero EC, Castells A, Engel P, Postigo A. ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatinremodeling protein BRG1. Oncogene. 2010; 29:3490-3500.
31. Nilsson J, Helou K, Kovács A, Bendahl PO, Bjursell G, Fernö M, Carlsson P, Kannius-Janson M. Nuclear Janus-activated kinase 2/nuclear factor 1-C2 suppresses tumorigenesis and epithelial-to-mesenchymal transition by repressing Forkhead box F1. Cancer Res. 2010; 70:2020-2029.
32. Qiao Y, Jiang X, Lee ST, Karuturi RK, Hooi SC, Yu Q. FOXQ1 regulates epithelial-mesenchymal transition in human cancers. Cancer Res. 2011; 71:3076-3086.
33. U.D. Kahlert, G. Nikkhah, J. Maciaczyk. Epithelial-tomesenchymal(-like) transition as a relevant molecular event in malignant gliomas. Cancer Letters. 2013; 331:131-138.
34. Zeisberg M, Neilson EG. Biomarkers for epithelialmesenchymal transitions. J Clin Invest. 2009; 119:1429-1437.
35. CHENWEI LI, JING JIANG WU, MARK HYNES. C-Met Is a Marker of Pancreatic Cancer Stem Cells and Therapeutic Target. Gastroenterology. 2011; 141:2218-2227.